Glenmark Life Sciences dips on Glenmark Pharma’s plan to exit
Development comes about 10 months after Glenmark Pharma sold 75 percent stake in GLS to Nirma
Development comes about 10 months after Glenmark Pharma sold 75 percent stake in GLS to Nirma